Active Ingredient History

  • Now
Lumiliximab is an IgG1k monoclonal antibody that targets CD23. It acts as an immunomodulator and was awarded orphan drug status and fast track designation by the FDA.   Wikipedia

More Chemistry
gomiliximab | idec-152 | lumiliximab | monoclonal antibody lumiliximab | p5e8 si-3401 gomiliximab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue